Cargando…
Alendronate/cRGD-Decorated Ultrafine Hyaluronate Dot Targeting Bone Metastasis
In this study, we report the hyaluronate dot (dHA) with multiligand targeting ability and a photosensitizing antitumor model drug for treating metastatic bone tumors. Here, the dHA was chemically conjugated with alendronate (ALN, as a specific ligand to bone), cyclic arginine-glycine-aspartic acid (...
Autores principales: | Lee, Eunsol, Park, Jaeduk, Youn, Yu Seok, Oh, Kyung Taek, Kim, Dongin, Lee, Eun Seong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7696888/ https://www.ncbi.nlm.nih.gov/pubmed/33187133 http://dx.doi.org/10.3390/biomedicines8110492 |
Ejemplares similares
-
Profiling target engagement and cellular uptake of cRGD-decorated clinical-stage core-crosslinked polymeric micelles
por: De Lorenzi, Federica, et al.
Publicado: (2022) -
Systemic Administration of siRNA via cRGD-containing Peptide
por: Huang, Yuanyu, et al.
Publicado: (2015) -
Enhanced Specificity and Drug Delivery in Tumors by cRGD - Anchoring Thermosensitive Liposomes
por: Dicheva, Bilyana M., et al.
Publicado: (2015) -
cRGD Urokinase Liposomes for Thrombolysis in Rat Model of Acute Pulmonary Microthromboembolism
por: Liang, Chunting, et al.
Publicado: (2022) -
Protective effect of Gelofusine against cRGD-siRNA-induced nephrotoxicity in mice
por: Liao, Wenjie, et al.
Publicado: (2018)